All Updates

All Updates

icon
Filter
Partnerships
Caris Life Sciences partners with Incyte
Precision Medicine
Mar 7, 2023
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Mar 7, 2023

Caris Life Sciences partners with Incyte

Partnerships

  • Molecular profiling company Caris Life Sciences partners with global biopharmaceutical company Incyte to enhance precision medicine strategies for Incyte’s cancer drug development program. 

  • Under the terms of the agreement, Incyte will utilize Caris’ data analysis and insight capabilities to identify new biomarkers and optimize the clinical placement of its cancer treatment programs. For drugs that result from this collaboration, patients participating in Incyte-led clinical trials will undergo testing with Caris’ extensive tissue and liquid molecular profiling tests. Incyte will also use Caris’ biomarker-based patient selection clinical trials, which include the option to collaborate on developing companion diagnostics for programs involved in the partnership.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.